Abstract
A new 4‐deacety‐1,7,9‐trideoxy‐10‐oxopaclitaxel (compound 1) was prepared in 21 steps via sinenxan A, a biosynthetic taxane. The biological evaluation in vitro against human cancer lines showed compound 1 to be devoid of cytotoxicity.
Acknowledgments
This authors gratefully acknowledge financial supported of this work by National Natural Science Foundation of China (Project No. 30572243) and Beijing Natural Science Foundation (Project No. 7062048). We thank Jungui Dai for kindly providing Sinenxan A (SIA).